Bionest Partners Finance
  • EXPERTISE
    • Capital Raising
    • Partnership
    • M&A
    • Valuation Advisory
  • ABOUT US
  • TRANSACTIONS
  • CONTACT US
  • EN
  • FR
Select Page
2018 : Endo-Pharmaceuticals acquires Bioprojet’s Wakix commercial rights in Canada

2018 : Endo-Pharmaceuticals acquires Bioprojet’s Wakix commercial rights in Canada

by gdm5 | Oct 28, 2018 | Feature

2018 : Licensing-out Advisory for Acteon

2018 : Licensing-out Advisory for Acteon

by gdm5 | May 28, 2018 | Feature

2017 : Harmony Biosciences acquires Bioprojet’s Wakix commercial rights in the US

2017 : Harmony Biosciences acquires Bioprojet’s Wakix commercial rights in the US

by gdm5 | Nov 28, 2017 | Feature

2016 : AFM Telethon sells Trophos’ Olesoxime commercial rights to Roche Pharmaceuticals

2016 : AFM Telethon sells Trophos’ Olesoxime commercial rights to Roche Pharmaceuticals

by gdm5 | Dec 2, 2016 | Feature

2016 : M&A Buy Side Advisory for Vifor Pharmaceuticals in European specialty pharma transaction

2016 : M&A Buy Side Advisory for Vifor Pharmaceuticals in European specialty pharma transaction

by gdm5 | Oct 28, 2016 | Feature

« Older Entries
Next Entries »

Recent Posts

  • 2025 : Azalea Vision secures a 9m€ financing in a first series A closing
  • 2024 : AdScientiam secures an undisclosed financing to fuel its growth
  • 2024: Primaa secures pre-series A financing
  • 2024: InHeart secures 10m€ series A financing
  • 2023: Novadip secures 18M€ venture loan financing with EIB

Recent Comments

No comments to show.
  • Follow